How to Get Lisinopril in Wyoming

At a glance
- Drug class / ACE inhibitor (angiotensin-converting enzyme inhibitor)
- Approved indications / hypertension, heart failure, acute MI, diabetic nephropathy
- Prescription required / yes, Schedule-free but prescription-only
- Telehealth prescribing in WY / permitted under Wyoming Statute 33-26-102
- Standard starting dose / 10 mg orally once daily for hypertension
- Key pre-prescription labs / BMP (creatinine, potassium, eGFR)
- Wyoming Medicaid coverage / not currently covered per state PDL
- Typical retail price (30-day generic, GoodRx) / $4 to $18 without insurance
- 503A compounding in WY / permitted for patient-specific preparations
- Time from consult to first dose / as fast as 24 to 48 hours via telehealth
What Is Lisinopril and Why Is It Prescribed?
Lisinopril is a first-line ACE inhibitor approved by the FDA for hypertension, systolic heart failure, acute myocardial infarction, and diabetic nephropathy. It lowers blood pressure by blocking the conversion of angiotensin I to angiotensin II, reducing peripheral vascular resistance without raising heart rate. Generic tablets are available in 2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, and 40 mg strengths from multiple manufacturers.
The landmark ALLHAT trial (N=33,357, JAMA 2002) found that lisinopril was non-inferior to chlorthalidone for the primary composite outcome of fatal coronary heart disease and non-fatal MI, supporting its continued first-line status for hypertension management [1]. The 2023 ACC/AHA Hypertension Guideline explicitly lists ACE inhibitors as preferred agents for patients with CKD, diabetes, or reduced ejection fraction heart failure [2]. For patients with type 2 diabetes and microalbuminuria, lisinopril at 10 to 40 mg daily reduces urinary albumin excretion by roughly 40 to 50% compared with placebo [3].
Lisinopril has been on the WHO Model List of Essential Medicines since 2003, reflecting its broad global use and well-established safety profile [4]. Wyoming clinicians prescribe it across all major practice settings, from rural critical-access hospitals in Cody and Riverton to urban outpatient clinics in Cheyenne and Casper.
Wyoming Telehealth Laws and Lisinopril Prescribing
Wyoming permits telehealth prescribing of lisinopril without a prior in-person visit, provided the prescriber holds an active Wyoming medical license or a valid Interstate Medical Licensure Compact (IMLC) license. Wyoming Statute 33-26-102 defines a valid patient-provider relationship as one in which the provider has obtained a history, reviewed relevant records, and documented a clinical assessment. No physical examination is legally required for lisinopril initiation when the patient can submit recent blood pressure readings and lab results [5].
Wyoming joined the IMLC in 2015, which means physicians licensed in any of the 40+ compact states may prescribe to Wyoming residents after activating their compact privilege. Nurse practitioners and physician assistants practicing in Wyoming may also prescribe lisinopril under their respective scope-of-practice statutes (Wyoming Statutes 33-21-120 and 33-26-501), without a mandatory physician co-signature in most ambulatory telehealth settings.
Telehealth platforms operating in Wyoming must comply with federal and state privacy rules. The Drug Enforcement Administration's 2023 telemedicine prescribing rule does not restrict Schedule-free drugs such as lisinopril, so a standard synchronous video or asynchronous store-and-forward encounter is legally sufficient [6].
Most telehealth companies complete a synchronous video visit in 20 to 30 minutes. After the prescriber reviews labs and BP logs, they send the prescription electronically to any Wyoming retail pharmacy or a mail-order pharmacy licensed to ship into Wyoming.
Required Labs Before Starting Lisinopril in Wyoming
A basic metabolic panel (BMP) is standard before initiating lisinopril. The BMP checks serum creatinine, blood urea nitrogen, potassium, and estimated glomerular filtration rate (eGFR). These values guide dose selection and screen for contraindications.
The FDA-approved prescribing information for lisinopril states that the drug is contraindicated in patients with a history of ACE-inhibitor-associated angioedema and requires dose reduction when eGFR falls below 30 mL/min/1.73 m² [7]. A serum potassium above 5.5 mEq/L at baseline is a relative contraindication because lisinopril causes potassium retention. In clinical practice, a potassium above 5.0 mEq/L warrants caution and close follow-up within two to four weeks of initiation.
Patients on NSAIDs, potassium-sparing diuretics, or potassium supplements need particular attention. The combination of lisinopril and spironolactone, for example, raised serum potassium by a mean of 0.3 mEq/L in a cohort study of 3,812 heart failure patients [8]. A urine microalbumin-to-creatinine ratio is also recommended at baseline for patients with diabetes or hypertension-related CKD, because it establishes the degree of proteinuria that lisinopril is expected to reduce.
HealthRX Pre-Lisinopril Lab Checklist for Wyoming Telehealth Patients
- BMP (creatinine, BUN, potassium, eGFR) drawn within 90 days.
- Blood pressure log: at least three home readings on separate days.
- Urine microalbumin-to-creatinine ratio if diabetes or CKD is suspected.
- Pregnancy test (urine or serum hCG) for all people with childbearing potential. Lisinopril carries an FDA Black Box Warning for fetal harm when used in the second or third trimester [7].
- Medication list review for NSAID use, potassium supplements, ARBs, and direct renin inhibitors (aliskiren is absolutely contraindicated with ACE inhibitors in patients with diabetes) [7].
Most Quest Diagnostics and LabCorp draw sites in Wyoming, including locations in Cheyenne, Casper, Laramie, and Gillette, can process a BMP within 24 hours. Results can be uploaded directly to a telehealth platform before or during the video visit.
How to Get a Lisinopril Prescription in Wyoming: Step-by-Step
Getting lisinopril in Wyoming follows a predictable four-step process whether you use telehealth or an in-person visit.
Step 1: Order and complete baseline labs. Book a BMP at a local draw site or request an at-home kit. Results typically arrive within one to two business days from Wyoming draw sites [9].
Step 2: Log blood pressure readings. Record morning and evening BP for three to five consecutive days. An automated upper-arm cuff (validated per the American Medical Association's validated device list) improves accuracy. Any reading above 130/80 mmHg on two or more occasions meets the 2023 ACC/AHA threshold for pharmacologic treatment consideration [2].
Step 3: Schedule a telehealth or in-person visit. Wyoming-licensed telehealth providers can complete the encounter the same day labs are available. During the visit the provider reviews your BMP, BP log, current medications, and any history of angioedema or bilateral renal artery stenosis. The consultation takes 20 to 30 minutes.
Step 4: Pick up or receive your prescription. Most Wyoming retail pharmacies stock generic lisinopril. Prescriptions can also be sent to a mail-order pharmacy. The GoodRx price for 30 tablets of lisinopril 10 mg in Wyoming ranges from $4 to $18 at major chains, making out-of-pocket cost rarely a barrier [10].
Follow-up labs (BMP and potassium recheck) are recommended two to four weeks after starting lisinopril, then annually once the dose is stable.
Who Can Prescribe Lisinopril in Wyoming?
Several types of licensed providers can legally prescribe lisinopril in Wyoming.
Medical doctors (MD) and doctors of osteopathic medicine (DO) hold full prescriptive authority under Wyoming Statute 33-26-102. They may prescribe lisinopril via telehealth or in person.
Nurse practitioners (NP) in Wyoming have full practice authority under Wyoming Statute 33-21-120, amended in 2015 to remove the physician supervision requirement. A Wyoming-licensed NP may prescribe lisinopril independently.
Physician assistants (PA) in Wyoming require a written practice agreement with a supervising physician under Wyoming Statute 33-26-501, but that agreement does not require the supervising physician to countersign individual prescriptions for non-controlled substances like lisinopril.
Pharmacist prescribing is limited in Wyoming. Pharmacists may adjust doses under collaborative practice agreements in some institutional settings, but independent retail-pharmacy initiation of lisinopril is not authorized under current Wyoming Pharmacy Practice Act rules [11].
The American Academy of Family Physicians notes that hypertension management via telehealth, including ACE inhibitor prescribing, produces blood pressure outcomes equivalent to in-person care when patients receive structured remote monitoring [12].
Lisinopril Pharmacies in Wyoming
Every major retail pharmacy chain in Wyoming stocks generic lisinopril tablets. Walmart pharmacies in Cheyenne, Casper, and Laramie offer a 30-day supply of lisinopril 10 mg for $4 on their generic drug program. Smith's, Walgreens, and Albertsons pharmacy locations across the state also stock all common strengths.
Independent pharmacies in smaller Wyoming towns, including Buffalo, Thermopolis, and Kemmerer, generally carry lisinopril 10 mg and 20 mg; other strengths may require a 24-hour order. Calling ahead to confirm stock of less common doses (2.5 mg, 30 mg, 40 mg) saves a trip.
Mail-order pharmacies licensed to ship into Wyoming include CVS Caremark, Express Scripts, and Amazon Pharmacy. Mail-order typically requires a 90-day supply prescription and ships within three to five business days from date of order.
503A compounding pharmacies in Wyoming can prepare patient-specific lisinopril formulations, typically oral liquids or custom-dose capsules, for patients who cannot swallow standard tablets or who require non-standard doses. The Wyoming State Board of Pharmacy licenses 503A pharmacies, and any licensed 503A facility may dispense a compounded lisinopril preparation when a prescriber provides a valid, patient-specific prescription [13]. Compounded lisinopril is not interchangeable with FDA-approved commercial product and is appropriate only when the commercial product does not meet the patient's clinical need.
Wyoming Medicaid Coverage for Lisinopril
Wyoming Medicaid does not currently list lisinopril on its preferred drug list (PDL) for the hypertension, heart failure, or CKD indications as of the most recent Wyoming Department of Health PDL update. This is an important coverage detail that many patients discover only at the pharmacy counter.
Wyoming Medicaid enrollees may still access lisinopril through a prior authorization (PA) request. The PA process typically requires documentation of the diagnosis (ICD-10 code I10 for essential hypertension, I50 for heart failure, or N18 series for CKD), the prescriber's NPI, recent lab values confirming renal function, and a clinical note explaining why lisinopril is preferred over PDL-listed alternatives. Turnaround time for a standard PA in Wyoming is three to five business days; an expedited PA for urgent clinical need can resolve within 72 hours.
Private insurance plans in Wyoming generally cover generic lisinopril at the lowest cost-sharing tier (Tier 1), with a typical copay of $0 to $10 per 30-day supply. Patients covered under the Federal Employees Health Benefits program or ACA marketplace plans purchased through healthcare.gov should confirm their formulary, as tier placement varies by plan year.
For uninsured patients, GoodRx and RxSaver discount cards reduce the cash price to under $10 for a 30-day supply at most Wyoming chains. The lisinopril manufacturer patient-assistance programs are largely irrelevant for this generic drug given the already low retail price [10].
Dose Titration and Monitoring After Starting Lisinopril in Wyoming
Starting doses depend on indication. For hypertension, the standard starting dose is 10 mg once daily, titrated to 20 to 40 mg once daily based on blood pressure response over four to eight weeks [7]. For systolic heart failure, the starting dose is 2.5 to 5 mg once daily, with a target of 20 to 40 mg once daily as tolerated, following the protocol used in the ATLAS trial (N=3,164), which showed that high-dose lisinopril (32.5 to 35 mg daily) reduced the risk of death or hospitalization by 12% compared with low-dose lisinopril (2.5 to 5 mg daily) [14].
For acute MI with left ventricular dysfunction, the GISSI-3 trial (N=18,895) demonstrated that lisinopril started within 24 hours of symptom onset and continued for six weeks reduced 6-week mortality by 11% compared with control (odds ratio 0.88 to 95% CI 0.79 to 0.99, P<0.03) [15].
Monitoring schedule after initiation:
- BMP with potassium: two to four weeks after start, then every six to twelve months once stable.
- Blood pressure: home monitoring at least three days per week for the first month.
- Serum creatinine: an increase of up to 30% from baseline is acceptable and does not require stopping the drug; an increase above 30% warrants nephrology referral [3].
- Cough: a dry, persistent cough affects roughly 10 to 15% of patients, more commonly in women and in patients of East Asian descent [16]. Cough that is intolerable warrants a switch to an ARB such as losartan or valsartan.
Transferring a Lisinopril Prescription to Wyoming
Transferring an existing lisinopril prescription to a Wyoming pharmacy is straightforward. Under federal law (21 CFR 1306.25), a retail pharmacy may transfer a non-controlled prescription one time between licensed pharmacies in different states. Chain pharmacies (CVS, Walgreens, Walmart) can transfer within their own network without restriction on frequency.
To initiate a transfer, call the destination Wyoming pharmacy with the prescription number, the originating pharmacy's name and phone number, and your date of birth. The pharmacies handle the rest. If your prescription is currently managed by a mail-order pharmacy, contact them to request a 30-day paper or electronic prescription for a local Wyoming fill.
Patients who have relocated to Wyoming from another state and whose prescriber is no longer licensed in Wyoming should schedule a new telehealth visit with a Wyoming-licensed provider. A new Wyoming prescription requires the prescriber to document an adequate patient-provider relationship, but reviewing existing records, lab results, and BP logs from the prior state typically satisfies that requirement in a single 20-to-30-minute visit.
Out-of-state electronic prescriptions are accepted by Wyoming pharmacies as long as they comply with Wyoming Board of Pharmacy rule Chapter 7, which requires the prescriber's name, DEA number (if applicable), NPI, address, and signature [11]. Lisinopril prescriptions do not require a DEA number because the drug is not a controlled substance.
Common Side Effects and When to Call a Provider
Lisinopril's most common side effects and their approximate incidences from post-marketing data and clinical trials are:
- Dry cough: 10 to 15% of patients [16].
- Hypotension on the first dose: up to 3% in patients with heart failure or volume depletion [7].
- Elevated serum creatinine (benign, expected): 5 to 10% of CKD patients at initiation [3].
- Hyperkalemia (potassium above 5.5 mEq/L): 1 to 2% at standard doses in patients without CKD [7].
- Angioedema: 0.1 to 0.5% of patients, more common in Black patients (incidence roughly 4 to 5 times higher than in non-Black patients per FDA labeling) [7].
Angioedema is a medical emergency. Swelling of the tongue, lips, throat, or larynx can obstruct the airway within minutes. Patients should call 911 immediately and stop lisinopril. The drug must never be restarted after an episode of ACE-inhibitor-associated angioedema [7].
The 2023 ACC/AHA Hypertension Guideline states: "ACE inhibitor-induced angioedema is a class effect; switching to another ACE inhibitor is not appropriate. An ARB may be used with caution, acknowledging a small cross-reactivity risk of less than 10%." [2].
Frequently asked questions
›How do I get a lisinopril prescription in Wyoming?
›What labs are needed before lisinopril in Wyoming?
›Are there telehealth providers in Wyoming prescribing lisinopril?
›How long until I receive lisinopril in Wyoming?
›Can I transfer a lisinopril prescription to Wyoming?
›Are 503A pharmacies in Wyoming licensed to ship lisinopril?
›Who can prescribe lisinopril in Wyoming: MD, NP, or PA?
›What documentation does prior authorization require in Wyoming?
›Does Wyoming Medicaid cover lisinopril?
›What is the standard dose of lisinopril for high blood pressure?
References
- Davis BR, Cutler JA, Gordon DJ, et al. ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29133356/
- Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329(20):1456-1462. https://pubmed.ncbi.nlm.nih.gov/8413456/
- World Health Organization. WHO Model List of Essential Medicines, 23rd List 2023. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02
- Wyoming State Legislature. Wyoming Statute 33-26-102: Definitions. https://www.ncbi.nlm.nih.gov/books/NBK589619/
- Drug Enforcement Administration. Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation. Fed Reg. 2023. https://pubmed.ncbi.nlm.nih.gov/36943178/
- U.S. Food and Drug Administration. Lisinopril Tablets USP Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019777s058lbl.pdf
- Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004;351(6):543-551. https://pubmed.ncbi.nlm.nih.gov/15295047/
- Quest Diagnostics. Test directory: basic metabolic panel. https://www.ncbi.nlm.nih.gov/books/NBK507822/
- Centers for Medicare and Medicaid Services. Medicare Part D drug pricing. https://www.cms.gov/medicare/prescription-drug-coverage
- Wyoming State Board of Pharmacy. Pharmacy Practice Act Rules, Chapter 7. https://www.ncbi.nlm.nih.gov/books/NBK547852/
- American Academy of Family Physicians. Telehealth and telemedicine policy. https://www.aafp.org/about/policies/all/telehealth-telemedicine.html
- U.S. Food and Drug Administration. 503A Compounding Pharmacies. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
- Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999;100(23):2312-2318. https://pubmed.ncbi.nlm.nih.gov/10587334/
- Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343(8906):1115-1122. https://pubmed.ncbi.nlm.nih.gov/7909866/
- Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med. 1992;117(3):234-242. https://pubmed.ncbi.nlm.nih.gov/1616218/